https://www.selleckchem.com/pr....oducts/l-dehydroasco
BACKGROUND Little is known about the prevalence, predictors, and outcomes of late vasopressor administration which evolves after admission to the ICU. METHODS We retrospectively studied a cohort of Veterans admitted to the Veterans Administration ICUs for ≥ 4 days from 2014-2017. The timing of vasopressor administration was categorized as early (only within the initial 3 days), late (on ≥ day 4 and none on day 3) and continuous (within the initial 2 days through at least day 4). Regressions were performed to identify pati
Like
Comment
Share
